Programmed Cell Death News and Research

RSS
FORT-2 trial shows promising results for bladder cancer immunotherapy combination

FORT-2 trial shows promising results for bladder cancer immunotherapy combination

Review highlights mitochondrial dysfunction in cholestatic liver injury

Review highlights mitochondrial dysfunction in cholestatic liver injury

Salt can boost antitumor responses of T cells

Salt can boost antitumor responses of T cells

Pyroptosis found to promote wound healing and tissue repair

Pyroptosis found to promote wound healing and tissue repair

New insights on how melanoma cells resist cancer immunotherapy

New insights on how melanoma cells resist cancer immunotherapy

Understanding host immune responses through cell death pathways

Understanding host immune responses through cell death pathways

Discovery of immune cell regulator could lead to new therapies for inflammatory conditions

Discovery of immune cell regulator could lead to new therapies for inflammatory conditions

New target identified for melanoma resistant to current therapies

New target identified for melanoma resistant to current therapies

FDA accepted PD-L1 inhibitor durvalumab for the treatment of endometrial cancer

FDA accepted PD-L1 inhibitor durvalumab for the treatment of endometrial cancer

Review highlights unique characteristics and mechanisms of ferroptosis

Review highlights unique characteristics and mechanisms of ferroptosis

Advancements in immunotherapy for hepatocellular carcinoma offer hope to patients

Advancements in immunotherapy for hepatocellular carcinoma offer hope to patients

Duke researchers discover drug to restore aged livers

Duke researchers discover drug to restore aged livers

Canagliflozin enhances senescent cell clearance, improving aging-related conditions

Canagliflozin enhances senescent cell clearance, improving aging-related conditions

Canagliflozin: A breakthrough in senolytic treatment for aging-related diseases

Canagliflozin: A breakthrough in senolytic treatment for aging-related diseases

Review highlights the rapidly evolving landscape of hepatocellular carcinoma treatment

Review highlights the rapidly evolving landscape of hepatocellular carcinoma treatment

Wayne State University researcher receives NIH grant to tackle diabetic eye infections

Wayne State University researcher receives NIH grant to tackle diabetic eye infections

Study unveils novel bladder cancer diagnostic model based on key mitochondrial genes

Study unveils novel bladder cancer diagnostic model based on key mitochondrial genes

Study reveals key protein's role in balancing immune response to viral infections

Study reveals key protein's role in balancing immune response to viral infections

U-M study reveals potential pathway to reverse lung fibrosis

U-M study reveals potential pathway to reverse lung fibrosis

Dartmouth research unlocks extended cell death pathway in aging brain cells

Dartmouth research unlocks extended cell death pathway in aging brain cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.